Seeking AlphaTue, 12 May 2026 14:24:05 GMTUniQure Q1 Earnings Review: Limited Progress With FDA, But UK Approval In PlayQURE+0.24%
Seeking AlphaTue, 05 May 2026 19:41:26 GMTuniQure N.V. (QURE) Q1 2026 Earnings Call TranscriptQURE+0.24%
Zacks Investment ResearchTue, 05 May 2026 13:26:11 GMTuniQure (QURE) Reports Q1 Loss, Misses Revenue EstimatesQURE+0.24%
Market WatchMon, 09 Mar 2026 13:18:00 GMTThis biotech's stock is soaring after a ‘polarizing' FDA official is stepping downQURE+0.24%
Zacks Investment ResearchFri, 06 Mar 2026 16:01:03 GMTQURE Stock Crashes 32% in a Week: Here's What You Should KnowQURE+0.24%
WSJThu, 05 Mar 2026 23:01:00 GMTFederal health officials attacked an Amsterdam-based biotech company seeking approval of a Huntington's disease treatment and accused it of lyingQURE+0.24%
CNBCThu, 05 Mar 2026 19:42:13 GMTFDA official calls UniQure's gene therapy a 'failed' treatment for Huntington's diseaseQURE+0.24%
BenzingaThu, 05 Mar 2026 17:11:04 GMTFDA Defends Call For Placebo Study In uniQure Huntington's Gene Therapy TrialQURE+0.24%
Zacks Investment ResearchWed, 04 Mar 2026 15:36:05 GMTuniQure (QURE) Loses 67.5% in 4 Weeks, Here's Why a Trend Reversal May be Around the CornerQURE+0.24%
BenzingaTue, 03 Mar 2026 14:34:05 GMTThese Analysts Cut Their Forecasts On uniQure Following Q4 ResultsQURE+0.24%
Seeking AlphaTue, 03 Mar 2026 13:15:20 GMTuniQure: The Worst Case Scenario Just Got Official (Rating Downgrade)QURE+0.24%
Seeking AlphaMon, 02 Mar 2026 21:27:50 GMTuniQure N.V. (QURE) Q4 2025 Earnings Call TranscriptQURE+0.24%
Zacks Investment ResearchMon, 02 Mar 2026 14:21:10 GMTuniQure (QURE) Reports Q4 Loss, Misses Revenue EstimatesQURE+0.24%
Investors Business DailyMon, 02 Mar 2026 13:58:49 GMTUniqure Plummets More Than 40% On Another Twist In Its Gene Therapy SagaQURE+0.24%
Seeking AlphaFri, 27 Feb 2026 15:49:58 GMTuniQure: Shares Tumble On Fresh FDA Controversy - What Investors Should KnowQURE+0.24%
